Table of Content

1. Executive Summary

1.1. Regional Market Share

1.2.Business Trends

1.3.Prothrombin Complex Concentrate Market: COVID-19 Outbreak

1.4. Regional Trends

1.5. Segmentation Snapshot


2. Research Methodology

2.1.Research Objective

2.2. Research Approach

2.3. Data Sourcing and Methodology

2.4.Primary Research

2.5.Secondary Research

2.5.1. Paid Sources

2.5.2. Public Sources

2.6. Market Size Estimation and Data Triangulation


3. Market Characteristics

3.1.Market Definition

3.2.Prothrombin Complex Concentrate Market: COVID-19 Impact

3.3. Key Segmentations

3.4.Key Developments

3.5.Allied Industry Data


4. Prothrombin Complex Concentrate Market – Industry Insights

4.1. Industry Segmentation

4.2.COVID-19 overview on world economy

4.3.Industry ecosystem Channel analysis

4.4.Innovation & Sustainability


5. Macroeconomic Indicators


6. Recent Developments


7. Market Dynamics

7.1.Introduction

7.2. Growth Drivers

7.3. Market Opportunities

7.4.Market Restraints

7.5. Market Trends


8. Risk Analysis


9. Market Analysis

9.1.Porters Five Forces

9.2. PEST Analysis

9.2.1.Political

9.2.2. Economic

9.2.3. Social

9.2.4. Technological

10.Prothrombin Complex Concentrate Market

10.1.Overview

10.2. Historical Analysis (2016-2021)

10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast


11. Prothrombin Complex Concentrate Market Size & Forecast 2022A-2032F

11.1. Overview

11.2.Key Findings

11.3.Market Segmentation

11.3.1. By Product

11.3.1.1. 3-Factor PCC

11.3.1.1.1.By Value (USD Million) 2022-2032F

11.3.1.1.2. Market Share (%) 2022-2032F

11.3.1.1.3. Y-o-Y Growth (%) 2022-2032F

11.3.1.2.4-Factor PCC

11.3.1.2.1. By Value (USD Million) 2022-2032F

11.3.1.2.2.Market Share (%) 2022-2032F

11.3.1.2.3.Y-o-Y Growth (%) 2022-2032F

11.3.2. By Application

11.3.2.1.Congenital Coagulation Factor Deficiency

11.3.2.1.1. By Value (USD Million) 2022-2032F

11.3.2.1.2.Market Share (%) 2022-2032F

11.3.2.1.3.Y-o-Y Growth (%) 2022-2032F

11.3.2.2. Acquired Coagulation Factor Deficiency

11.3.2.2.1.By Value (USD Million) 2022-2032F

11.3.2.2.2. Market Share (%) 2022-2032F

11.3.2.2.3. Y-o-Y Growth (%) 2022-2032F

11.3.3.By End-Use

11.3.3.1.Hospitals

11.3.3.1.1. By Value (USD Million) 2022-2032F

11.3.3.1.2.Market Share (%) 2022-2032F

11.3.3.1.3.Y-o-Y Growth (%) 2022-2032F

11.3.3.2. Ambulatory Surgical Centres

11.3.3.2.1.By Value (USD Million) 2022-2032F

11.3.3.2.2. Market Share (%) 2022-2032F

11.3.3.2.3. Y-o-Y Growth (%) 2022-2032F

11.3.3.3. Specialty Clinics

11.3.3.3.1.By Value (USD Million) 2022-2032F

11.3.3.3.2. Market Share (%) 2022-2032F

11.3.3.3.3. Y-o-Y Growth (%) 2022-2032F

11.3.3.4. Others

11.3.3.4.1.By Value (USD Million) 2022-2032F

11.3.3.4.2. Market Share (%) 2022-2032F

11.3.3.4.3. Y-o-Y Growth (%) 2022-2032F

12.North America Prothrombin Complex Concentrate Market Size & Forecast 2022A-2032F

12.1.Overview

12.2. Key Findings

12.3. Market Segmentation

12.3.1. By Product

12.3.2.By Application

12.3.3.By End Use

12.4. Country

12.4.1. United States

12.4.2.Canada

13.Europe Prothrombin Complex Concentrate Market Size & Forecast 2022A-2032F

13.1.Overview

13.2. Key Findings

13.3. Market Segmentation

13.3.1.By Product

13.3.2.By Application

13.3.3.By End Use

13.4.Country

13.4.1. Germany

13.4.2.United Kingdom

13.4.3.France

13.4.4.Italy

13.4.5.Spain

13.4.6.Russia

13.4.7.Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)

14.Asia Prothrombin Complex Concentrate Market Size & Forecast 2022A-2032F

14.1. Overview

14.2. Key Findings

14.3.Market Segmentation

14.3.1.By Product

14.3.2. By Application

14.3.3. By End Use

14.4. Country

14.4.1. India

14.4.2.China

14.4.3.South Korea

14.4.4.Japan

14.4.5.Rest of APAC

15.Middle East and Africa Prothrombin Complex Concentrate Market Size & Forecast 2022A-2032F

15.1.Overview

15.2. Key Findings

15.3. Market Segmentation

15.3.1.By Product

15.3.2.By Application

15.3.3.By End Use

15.4.Country

15.4.1. Israel

15.4.2.GCC

15.4.3.North Africa

15.4.4.South Africa

15.4.5.Rest of Middle East and Africa


16. Latin America Prothrombin Complex Concentrate Market Size & Forecast 2022A-2032F

16.1.Overview

16.2. Key Findings

16.3. Market Segmentation

16.3.1. By Product

16.3.2.By Application

16.3.3.By End Use

16.4.Country

16.4.1.Mexico

16.4.2.Brazil

16.4.3.Rest of Latin America


17. Competitive Landscape

17.1.Company market share, 2021

17.2. Key player overview

17.3. Key stakeholders


18. Company Profiles

18.1. Octapharma AG

18.1.1.Company Overview

18.1.2. Financial Overview

18.1.3. Key Product; Analysis

18.1.4. Company Assessment

18.1.4.1. Product Portfolio

18.1.4.2. Key Clients

18.1.4.3.Market Share

18.1.4.4.Recent News & Development (Last 3 Yrs.)

18.1.4.5.Executive Team

18.2.Grifols S.A.

18.3.Novo Nordisk

18.4.CSL Behring GmbH

18.5.Kedrion Biopharma Inc.

18.6.China Biologic Products Holdings, Inc.

18.7.Shire Plc

18.8.Sanquin

18.9.Other Prominent Players

19. Appendix

20.Consultant Recommendation